{"id":"https://openalex.org/W2413636168","doi":null,"title":"High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.","display_name":"High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W2413636168","mag":"2413636168","pmid":"https://pubmed.ncbi.nlm.nih.gov/16761616"},"language":"en","primary_location":{"id":"pmid:16761616","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16761616","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of experimental & clinical cancer research : CR","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W2413636168"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010531543","display_name":"Patrizia Vici","orcid":"https://orcid.org/0000-0001-7528-9783","observed_orcids":["https://orcid.org/0000-0001-7528-9783"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P Vici","raw_affiliation_strings":["Division of Medical Oncology B, Regina Elena Institute for Cancer Research, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Medical Oncology B, Regina Elena Institute for Cancer Research, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037386575","display_name":"Elisabetta Maria Capomolla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"E Capomolla","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":null,"display_name":"P Foggi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"P Foggi","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020845536","display_name":"Silvia Carpano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"S Carpano","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109317818","display_name":"Francesca Conti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"F Conti","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040571142","display_name":"G Paoletti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"G Paoletti","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006245629","display_name":"Carolina Cauchi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C Cauchi","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077568624","display_name":"Laura Giacinti","orcid":"https://orcid.org/0009-0008-5368-2400","observed_orcids":["https://orcid.org/0009-0008-5368-2400"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"L Giacinti","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034522625","display_name":"Carlo Leonetti","orcid":"https://orcid.org/0000-0002-3526-7827","observed_orcids":["https://orcid.org/0000-0002-3526-7827"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"C Leonetti","raw_affiliation_strings":["Istituto Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086743021","display_name":"Diana Giannarelli","orcid":"https://orcid.org/0000-0002-6085-1195","observed_orcids":["https://orcid.org/0000-0002-6085-1195"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"D Giannarelli","raw_affiliation_strings":["Istituto Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111956881","display_name":"Massimo Lopez","orcid":"https://orcid.org/0000-0002-8610-4681","observed_orcids":["https://orcid.org/0000-0002-8610-4681"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"M Lopez","raw_affiliation_strings":["Istituto Nazionale Tumori Regina Elena"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale Tumori Regina Elena","institution_ids":["https://openalex.org/I4387152244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4387152244"],"apc_list":null,"apc_paid":null,"fwci":0.7483,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.71835294,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"25","issue":"1","first_page":"39","last_page":"44"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.9883000254631042,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.00989999994635582,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9330000281333923},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":1.0},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.7450000047683716},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8859999775886536},{"id":"https://openalex.org/keywords/heavily-pretreated-patients","display_name":"heavily pretreated patients","score":0.8389999866485596},{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.8980000019073486},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.8939999938011169},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5370000004768372},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7110000252723694},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7229999899864197},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.949999988079071}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.9383804798126221},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.900754988193512},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7038431763648987},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6934662461280823},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6812748908996582},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6475527286529541},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6179177761077881},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5303372144699097},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4445143938064575},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.4231216311454773},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3892345428466797}],"mesh":[{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016879","descriptor_name":"Salvage Therapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16761616","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16761616","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of experimental & clinical cancer research : CR","raw_type":"Journal Article"},{"id":"mag:2413636168","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16761616","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W18214132","https://openalex.org/W1520702439","https://openalex.org/W1812067939","https://openalex.org/W1837457249","https://openalex.org/W1888433797","https://openalex.org/W1898871412","https://openalex.org/W1907604566","https://openalex.org/W1997838307","https://openalex.org/W2013246214","https://openalex.org/W2013403355","https://openalex.org/W2045316633","https://openalex.org/W2068532424","https://openalex.org/W2069588715","https://openalex.org/W2070249221","https://openalex.org/W2089338192","https://openalex.org/W2118512375","https://openalex.org/W2126942676","https://openalex.org/W2129979963","https://openalex.org/W2139861053","https://openalex.org/W2150067367","https://openalex.org/W2151631271","https://openalex.org/W2160666145","https://openalex.org/W2242951200","https://openalex.org/W2329401292","https://openalex.org/W2376751074","https://openalex.org/W2994275270"],"related_works":["https://openalex.org/W2415573191","https://openalex.org/W2135323520","https://openalex.org/W1914910183","https://openalex.org/W35624067","https://openalex.org/W2232183530","https://openalex.org/W2040941344","https://openalex.org/W2329401292","https://openalex.org/W2246011925","https://openalex.org/W2403798061","https://openalex.org/W2993398695"],"abstract_inverted_index":{"The":[0],"treatment":[1],"of":[2,118,126,155,216,228,237],"refractory":[3],"metastatic":[4],"breast":[5,57,66,257],"cancer":[6,58,67,258],"is":[7],"primarily":[8],"palliative,":[9],"without":[10],"a":[11,29,60,261],"significant":[12],"impact":[13],"on":[14,59,89,109],"overall":[15,193],"survival.":[16],"Among":[17],"the":[18,127,217,229,238],"innovative":[19],"combinations":[20],"in":[21,37,52,145,152,168,177,181,185,208,214,226,235,254],"this":[22,146],"unfavourable":[23],"setting,":[24],"paclitaxel":[25,71],"and":[26,33,78,114,180,183,192,197,210,231],"gemcitabine":[27,79],"showed":[28],"possible":[30],"synergistic":[31],"action":[32],"an":[34],"encouraging":[35],"activity":[36],"some":[38],"clinical":[39],"trials.":[40],"This":[41],"phase":[42],"II":[43],"study":[44],"was":[45,202],"carried":[46],"out":[47,154],"to":[48,112,116,163,190,247],"evaluate":[49],"paclitaxel-gemcitabine":[50],"combination":[51,242],"very":[53,249,262],"heavily":[54,255],"pretreated":[55,256],"advanced":[56,65,138],"bi-weekly":[61],"schedule.Thirty-nine":[62],"women":[63],"with":[64,70,93,205,223,243,260],"were":[68,150,175,195,221],"treated":[69],"150":[72],"mg/m2":[73,81],"as":[74,82,251],"3":[75],"hrs":[76],"infusion,":[77,85],"1,500":[80],"30":[83],"mins":[84],"both":[86],"drugs":[87],"administered":[88],"days":[90,110],"1,":[91],"15,":[92],"cycles":[94],"repeated":[95],"every":[96,119],"28":[97],"days.":[98],"All":[99],"but":[100],"two":[101,123,132],"patients":[102,128,158,170],"received":[103,131],"granulocyte":[104],"colony":[105],"stimulating":[106],"factor":[107],"(G-CSF)":[108],"7":[111,169],"9":[113,196],"20":[115,198],"22":[117],"cycle.":[120],"More":[121],"than":[122],"third":[124],"(71%)":[125],"had":[129],"previously":[130],"or":[133],"more":[134],"chemotherapy":[135],"regimens":[136],"for":[137],"disease,":[139],"including":[140],"almost":[141],"all":[142],"active":[143,250],"agents":[144],"disease.":[147,187],"Objective":[148],"responses":[149],"observed":[151],"18":[153],"34":[156],"evaluable":[157],"(53%;":[159],"95%":[160],"CI,":[161],"36%":[162],"70%).":[164],"Disease":[165],"remained":[166],"stable":[167],"(21%).":[171],"Responses":[172],"by":[173],"sites":[174],"67%":[176],"soft":[178],"tissue":[179],"bone,":[182],"48%":[184],"visceral":[186],"Median":[188],"time":[189],"progression":[191],"survival":[194],"months,":[199],"respectively.":[200],"Treatment":[201],"well":[203],"tolerated,":[204],"G3-4":[206],"neutropenia":[207],"8%,":[209],"G":[211],"1-2":[212],"thrombocytopenia":[213],"13%":[215],"patients;":[218],"non-hematological":[219],"toxicities":[220],"mild,":[222],"G3":[224,232],"hepatotoxicity":[225],"5%":[227],"patients,":[230,259],"peripheral":[233],"neurotoxicity":[234],"10%":[236],"patients.":[239],"Biweekly":[240],"paclitaxel/gemcitabine":[241],"G-CSF":[244],"support":[245],"appears":[246],"be":[248],"salvage":[252],"therapy":[253],"favourable":[263],"safety":[264],"profile.":[265]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2413636168","counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
